The safest breast augmentation depends on several factors: the type of implant, its surface texture, where it’s placed in the chest, and whether you choose implants at all versus fat transfer. No option is risk-free, but the choices you make at each step meaningfully change your risk profile. Smooth-surface silicone implants placed beneath the chest muscle currently carry the lowest complication rates among implant-based options, while autologous fat transfer avoids implant-related risks entirely at the cost of more modest size increases.
Smooth vs. Textured Implant Surfaces
The single biggest safety distinction between implants is surface texture. Textured implants carry a risk of roughly 3 in 1,000 for developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer of the immune system that forms in the scar tissue around the implant. Smooth implants, by contrast, have a functionally zero risk. To date, there is no published case of BIA-ALCL in a woman known to have received only smooth implants. That difference isn’t a matter of degree; it’s categorical.
Textured surfaces were originally designed to reduce capsular contracture, a complication where scar tissue tightens painfully around the implant. They do lower that particular risk somewhat. But given the BIA-ALCL trade-off, most surgeons in the U.S. and several countries that have banned certain textured devices now favor smooth implants, especially since other strategies (like placement under the muscle) also reduce capsular contracture.
Silicone Gel, Saline, and “Gummy Bear” Implants
Modern silicone implants have gone through five generations of design improvements. The current standard, highly cohesive silicone gel (often called “gummy bear” implants), holds its shape even if the outer shell breaks. In long-term studies, these implants showed a rupture rate of 1.7% at a median of 8 years after surgery. A separate U.S. study found a slightly higher rate of 3.2% through 5 years, but both numbers are low by historical standards. When rupture does occur, the thick gel tends to stay in place rather than migrating through tissue, which was the major concern with older liquid silicone fills.
Capsular contracture rates for highly cohesive implants run about 5.3%, and all detected cases in long-term follow-up were moderate (grade 3), with no severe cases. Visible wrinkling or rippling, once a common complaint with saline implants, occurs in less than 1% of augmentation patients using these newer devices.
Saline implants remain an option and have one practical safety advantage: if they rupture, your body absorbs the saltwater harmlessly, and the deflation is immediately obvious. The trade-off is a less natural feel, higher wrinkling rates, and a slightly firmer result. For women who want to avoid any silicone inside their body, saline is the implant-based alternative.
Placement Under the Muscle Lowers Risk
Where the implant sits in your chest makes a measurable difference in long-term complications. Placing the implant beneath the pectoral muscle (subpectoral or “submuscular” placement) reduces capsular contracture rates significantly compared to placing it above the muscle, directly behind the breast tissue. A meta-analysis of over 17,700 cases found that submuscular placement cut the odds of capsular contracture by about 65%.
Submuscular placement also provides an extra layer of tissue coverage over the implant, which reduces visible rippling and can make mammograms slightly easier to read. The downside is a longer recovery, more discomfort in the first week or two, and a phenomenon called “animation deformity,” where the implant shifts visibly when you flex your chest. For most patients prioritizing long-term safety, the trade-off favors going under the muscle.
Fat Transfer as an Implant-Free Option
Autologous fat transfer uses liposuction to harvest fat from your abdomen, thighs, or flanks, then injects it into the breasts. It eliminates every implant-specific risk: no capsular contracture, no rupture, no BIA-ALCL, and no foreign material in your body.
The overall complication rate for breast fat transfer is about 7.5%. The most commonly reported issues are fat necrosis (where some transferred fat cells die and form firm lumps) at around 0.7% in large pooled analyses, though individual studies report rates anywhere from 3% to 17% depending on how much fat is injected and the technique used. Infection occurs in about 1% of cases. Calcifications, which can show up on mammograms and occasionally require follow-up imaging to distinguish from other findings, appear in roughly 0.6%.
The practical limitation is volume. Fat transfer typically adds one cup size or less per session, and a significant portion of the injected fat (sometimes 30% to 50%) gets reabsorbed by the body over the first few months. Many women need two or three sessions to reach their goal. You also need enough donor fat to harvest, which isn’t always available in leaner patients. For women wanting a subtle, natural increase and willing to accept multiple procedures, fat transfer is the option with the fewest serious long-term risks.
Breast Implant Illness: What the Data Shows
Some women with breast implants develop a cluster of systemic symptoms that don’t fit neatly into a single diagnosis. This is commonly called Breast Implant Illness (BII). The most frequently reported symptoms are fatigue (58%), joint pain (51%), muscle pain (44%), cognitive difficulties, sleep problems, and dry eyes or mouth. Symptoms typically appear about 6 years after implantation.
BII remains medically controversial because these symptoms overlap with many other conditions, and no diagnostic test confirms it. However, patterns in the data are hard to ignore. Among women reporting BII symptoms, about 21% have a diagnosed autoimmune condition, compared to lower rates in the general population. Roughly 12% have fibromyalgia, versus 2% to 3% in the general population. Blood tests for antinuclear antibodies (a marker of immune system activation) are positive in about 24% of BII patients, compared to 15% of the general population.
Women who have their implants removed for BII symptoms do so an average of 12.3 years after the original surgery. Many report improvement afterward, though the research on post-explantation outcomes is still limited. If minimizing this risk matters to you, fat transfer or simply choosing a smaller implant size (which correlates with less foreign material in the body) may be worth discussing with your surgeon.
Anesthesia and Surgical Setting
Breast augmentation can be performed under general anesthesia or with local anesthesia plus sedation. Local anesthesia with sedation avoids the risks of general anesthesia, which include rare but serious complications like breathing problems, adverse drug reactions, and longer recovery from grogginess. Surgeons with extensive experience using sedation-based protocols for breast augmentation report high satisfaction rates and no anesthesia-related complications across hundreds of cases.
That said, not every procedure or patient is suited to local anesthesia. Submuscular placement, for instance, involves more tissue manipulation and can be harder to keep comfortable without general anesthesia. The safest approach is whichever one your surgical team is most experienced with, performed in an accredited facility with proper monitoring equipment.
How to Minimize Your Overall Risk
If you’re choosing implants, the lowest-risk combination based on current evidence is a smooth-surface, highly cohesive silicone gel implant placed under the chest muscle. This combination minimizes capsular contracture, eliminates BIA-ALCL risk, reduces visible rippling, and uses the most durable modern shell technology.
If avoiding implants altogether is an option for your goals, fat transfer carries a lower ceiling of serious complications, though it requires realistic expectations about size. Regardless of method, choosing a board-certified plastic surgeon who performs the procedure regularly, in an accredited surgical facility, is the single most impactful safety decision you can make. Complication rates vary more between surgeons than between most implant types.